ICL
Showing 1 - 25 of 223
Refractive Errors, Myopia, Myopic Astigmatism Trial in Cairo (Refractive Surgery)
Recruiting
- Refractive Errors
- +2 more
- Refractive Surgery
-
Cairo, EgyptAlwatany Eye Hospital
Jan 1, 2023
Myopia, Myopic Astigmatism Trial in United States (EVO ICL)
Recruiting
- Myopia
- Myopic Astigmatism
- EVO ICL
-
Overland Park, Kansas
- +6 more
Sep 15, 2022
Quality of Vision in Implantable Collamer Lens (ICL)
Completed
- Pupil Diameter
-
Shenyang, Liaoning, ChinaHe Eye Specialist Hospital, Shenyang.
Jan 29, 2022
Binocular Vision Alternations and fMRI Activation After ICL
Recruiting
- Binocular Vision Disorder
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
Nov 30, 2022
Myopia Trial in Damietta (Implantable Collamer Lens (ICL), Implantable Intraocular Lens (IPCL))
Completed
- Myopia
- Implantable Collamer Lens (ICL)
- Implantable Intraocular Lens (IPCL)
-
Damietta, EgyptAkram Fekry Elgazzar
Sep 22, 2023
Tissue Biopsy and Imaging Studies in HIV-Infected Patients
Recruiting
- HIV
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Myopia, Myopic Astigmatism Trial in United States (EVO/EVO+ Visian ICL)
Active, not recruiting
- Myopia
- Myopic Astigmatism
- EVO/EVO+ Visian ICL
-
Phoenix, Arizona
- +13 more
Jul 1, 2022
Myopia Trial in China (viscoelastic-free implantation system, standard viscoelastic-assisted Implantation system)
Recruiting
- Myopia
- viscoelastic-free implantation system
- standard viscoelastic-assisted Implantation system
-
Guangzhou, Guangdong, China
- +4 more
Oct 4, 2021
Breast Cancer Trial in Vandœuvre-lès-Nancy (Analgesia Nociception Index)
Active, not recruiting
- Breast Cancer
- Analgesia Nociception Index
-
Vandœuvre-lès-Nancy, FranceInstitut de Cancérologie de Lorraine (ICL)
Mar 29, 2022
Melanoma (Skin) Trial in Dijon, Thionville, Vandœuvre-lès-Nancy (Blood sampling)
Active, not recruiting
- Melanoma (Skin)
- Blood sampling
-
Dijon, France
- +3 more
Mar 29, 2022
Thalassemia, Iron Overload Trial in Oakland (Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO))
Completed
- Thalassemia
- Iron Overload
- Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO)
-
Oakland, CaliforniaCHRCO
Jul 20, 2021
Beta-thalassemia, Iron Overload Trial in Los Angeles, Oakland, Chicago (Deferasirox)
Completed
- Beta-thalassemia
- Iron Overload
-
Los Angeles, California
- +2 more
Jun 8, 2021
Bone Sarcoma, Osteosarcoma, Ewing Sarcoma Trial in France (Treatment by Regorafenib, Treatment by Placebo)
Recruiting
- Bone Sarcoma
- +6 more
- Treatment by Regorafenib
- Treatment by Placebo
-
Besançon, France
- +15 more
Aug 18, 2022
Metastatic Renal Cell Carcinoma Trial in France (PRISM care program)
Recruiting
- Metastatic Renal Cell Carcinoma
- PRISM care program
-
Angers, France
- +11 more
Apr 22, 2022
Head and Neck Squamous Cell Carcinoma Trial in France, Germany, Spain (Cisplatin, 5-Fluorouracile, Docetaxel)
Completed
- Head and Neck Squamous Cell Carcinoma
- Cisplatin
- +4 more
-
Avignon, France
- +16 more
Aug 22, 2022
Retinal Microvascular Alteration After ICL Implantation
Completed
- Adolescent
- +13 more
- Optical Coherence Tomography Angiography
-
Beijing, Beijing, ChinaPeking University Third Hospital
Jun 22, 2020
Keratoconus Trial in Alexandria (PKP)
Completed
- Keratoconus
- PKP
-
Alexandria, EgyptAlexandria Faculty of Medicine
Jun 30, 2020
Myopia Trial in Asyut, Banha (Implantable Collamer Lens (ICL) in treatment of myopia in adults., Implantable Intraocular Lens
Unknown status
- Myopia
- Implantable Collamer Lens (ICL) in treatment of myopia in adults.
- Implantable Intraocular Lens (IPCL) in treatment of myopia in adults.
-
Asyut, Egypt
- +1 more
Nov 5, 2020
Idiopathic CD4-Positive, T-Lymphocytopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting
- Idiopathic CD4-Positive
- T-Lymphocytopenia
- Filgrastim
- Plerixafor
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Idiopathic CD4 T Cell Lymphocytopenia Trial run by the NIAID (Gardasil 9)
Recruiting
- Idiopathic CD4 T Cell Lymphocytopenia
- Gardasil 9
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 10, 2023
Idiopathic CD4 Lymphopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Recombinant human
Not yet recruiting
- Idiopathic CD4 Lymphopenia
- Recombinant human interleukin (IL) 7-hyFc
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023